Subtype
Female Reproductive System Neoplasm
CI-CAN-00000885Explore in graph →
Non-malignant1,630 active trials11 approved drugs139 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000885Explore in graph →
Clinical trials
7,171 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04890912 | Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus II(SPARTACUSII) | unknown | N/A | 50 | Sunnybrook Health Sciences CentreOTHER | 1 | Oct 25, 2021 | clinicaltrials |
| NCT05056259 | Usefulness of 18F-FDG PET/CT in the Initial Staging and Surveillance of Endometrial Cancer Patients(PET/CT) | unknown | — | 42 | Assiut UniversityOTHER | 0 | Oct 25, 2021 |
| clinicaltrials |
| NCT05086783 | Video-based Coaching (VBC) in Gynecologic Surgery | unknown | N/A | 30 | Mount Sinai Hospital, CanadaOTHER | 1 | Oct 21, 2021 | clinicaltrials |
| NCT00942357 | Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer | unknown | Phase 3 | 813 | Gynecologic Oncology GroupNETWORK | 3 | Oct 19, 2021 | clinicaltrials |
| NCT03979339 | Feasibility of a New Technology for Isolating Circulating Tumour Cells(CTC-SMMiL-E) | unknown | N/A | 76 | Centre Oscar LambretOTHER | 1 | Oct 13, 2021 | clinicaltrials |
| NCT04290299 | Endometrial Cancer Conservative Treatment (E.C.Co). A Multicentre Archive | unknown | — | 100 | National Cancer Institute, NaplesOTHER | 16 | Oct 13, 2021 | clinicaltrials |
| NCT04214782 | Detection of Ovarian Cancer Using an Artificial Intelligence Enabled Transvaginal Ultrasound Imaging Algorithm | unknown | N/A | 10,000 | Tongji HospitalOTHER | 0 | Oct 7, 2021 | clinicaltrials |
| NCT04214964 | Clinical Characters of the Diagnosis and Treatment of Gynecological Malignant Tumors in China : A Real World Study | unknown | — | 10,000 | Tongji HospitalOTHER | 1 | Oct 7, 2021 | clinicaltrials |
| NCT05068180 | Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients | unknown | Phase 4 | 200 | RenJi HospitalOTHER | 1 | Oct 6, 2021 | clinicaltrials |
| NCT05069818 | Variance of HRD From Paired Ovarian Cancer(HOPEII) | unknown | — | 50 | Xiaoxiang ChenOTHER | 1 | Oct 6, 2021 | clinicaltrials |
| NCT05065853 | Urinary and Vaginal HPV Testing in Cervical Cancer Screening | unknown | — | 330 | University of AarhusOTHER | 0 | Oct 4, 2021 | clinicaltrials |
| NCT00108745 | Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer | unknown | Phase 3 | 1,157 | GOG FoundationNETWORK | 1 | Sep 30, 2021 | clinicaltrials |
| NCT00954174 | Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer | unknown | Phase 3 | 637 | GOG FoundationNETWORK | 2 | Sep 30, 2021 | clinicaltrials |
| NCT01366183 | Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer | unknown | — | 290 | Gynecologic Oncology GroupNETWORK | 1 | Sep 30, 2021 | clinicaltrials |
| NCT01500512 | Observation in Patients With Early-Stage Vulvar Cancer Undergoing Sentinel Lymph Node Dissection(GROINSS-V) | unknown | — | 148 | Gynecologic Oncology GroupNETWORK | 2 | Sep 30, 2021 | clinicaltrials |
| NCT02065687 | Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer | unknown | Phase 2 / Phase 3 | 469 | Gynecologic Oncology GroupNETWORK | 1 | Sep 30, 2021 | clinicaltrials |
| NCT03570866 | PET/CT in the Management of Patients With Early Stage Endometrial Cancer(ENCA-1) | unknown | — | 40 | Università degli Studi dell'InsubriaOTHER | 0 | Sep 30, 2021 | clinicaltrials |
| NCT05059782 | Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer | unknown | N/A | 150 | Xi'an Jiaotong UniversityOTHER | 1 | Sep 28, 2021 | clinicaltrials |
| NCT02388698 | FDG-PET and Circulating HPV in Patients With Cervical Cancer | unknown | N/A | 84 | Sunnybrook Health Sciences CentreOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT04731038 | Combination Therapy for First Line Treatment of Advanced Cervical Cancer | unknown | Phase 1 | 20 | Ruijin HospitalOTHER | 1 | Sep 17, 2021 | clinicaltrials |
| NCT04867109 | HE4 in the Diagnostic Approach of Endometrial Cancer in Patients With Postmenopausal Bleeding(METRODEC) | unknown | — | 100 | Nantes University HospitalOTHER | 1 | Sep 17, 2021 | clinicaltrials |
| NCT05044091 | Homologous Recombination Deficiency in Chinese Ovarian Cancer Patients(HOPEI) | unknown | — | 100 | Xiaoxiang ChenOTHER | 1 | Sep 14, 2021 | clinicaltrials |
| NCT04935333 | Accuracy of the Preoperative Molecular Diagnosis of Uterine Tumors by Liquid Biopsy(MYOSARCII) | unknown | — | 600 | IgenomixINDUSTRY | 1 | Sep 10, 2021 | clinicaltrials |
| NCT00980759 | Prophylactic Irradiation of the Para-Aortic Lymph Nodes in Locally Advanced Uterine Cervical Cancer | unknown | N/A | 312 | National Cancer Center, KoreaOTHER_GOV | 1 | Sep 8, 2021 | clinicaltrials |
| NCT04217798 | Efficacy and Safety of Niraparib Combined With Oral Etoposide in Platinum Resistant/Refractory Recurrent Ovarian Cancer | unknown | Phase 2 | 36 | Peking Union Medical College HospitalOTHER | 1 | Sep 1, 2021 | clinicaltrials |
| NCT05026073 | Vibrational Spectroscopy for Endometrial Cancer Diagnosis(SPEED) | unknown | — | 150 | Nottingham University Hospitals NHS TrustOTHER | 1 | Aug 30, 2021 | clinicaltrials |
| NCT03462212 | Carboplatin-Paclitaxel-Bevacizumab vs Carbo-Pacli-Beva-Rucaparib vs Carbo-Pacli-Ruca, Selected According to HRD Status, in Patients With Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer, Preceded by a Phase I Dose Escalation Study on Ruca-Beva Combination(MITO25) | unknown | Phase 1 / Phase 2 | 290 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Aug 27, 2021 | clinicaltrials |
| NCT04238988 | Carboplatin-Paclitaxel-Pembrolizumab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer(MITO CERV 3) | unknown | Phase 2 | 45 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Aug 27, 2021 | clinicaltrials |
| NCT04679064 | Trial on NIraparib-TSR-042 (Dostarlimab) vs Physician's Choice CHEmotherapy in Recurrent, Ovarian, Fallopian Tube or Primary Peritoneal Cancer Patients Not Candidate for Platinum Retreatment(NItCHE-MITO33) | unknown | Phase 3 | 427 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Aug 27, 2021 | clinicaltrials |
| NCT02512848 | The Feasibility Study of the Li Brush for the Screening of Endometrial Cancer in the Postmenopausal Period | unknown | — | 100 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Aug 25, 2021 | clinicaltrials |
| NCT04617470 | Niraparib as Maintenance Treatment in Platinum Responsive Ovarian Cancer Patients: a Real Life Study(MITO 34) | unknown | — | 300 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Aug 25, 2021 | clinicaltrials |
| NCT05013268 | Tislelizumab Plus TP as Neoadjuvant Therapy for Local Advanced Cervical Carcinoma(TiTanec) | unknown | Phase 1 | 15 | Ruijin HospitalOTHER | 1 | Aug 24, 2021 | clinicaltrials |
| NCT05018195 | Adipocytokines in Endometrial Cancer(ACEmCa) | unknown | N/A | 200 | National Taiwan University HospitalOTHER | 0 | Aug 24, 2021 | clinicaltrials |
| NCT03814447 | The Fourth Generation CART-cell Therapy for Refractory-Relapsed Ovarian Cancer | unknown | Early Phase 1 | 10 | Shanghai 6th People's HospitalOTHER | 1 | Aug 10, 2021 | clinicaltrials |
| NCT04974827 | A Study of Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer | unknown | Phase 2 | 46 | Hunan Cancer HospitalOTHER | 1 | Aug 10, 2021 | clinicaltrials |
| NCT04267575 | Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites | unknown | N/A | 20 | Jerome Canady, M.D.OTHER | 1 | Aug 9, 2021 | clinicaltrials |
| NCT04887961 | Reprab Study: PLD + Trabectedin Rechallenge(MITO36) | unknown | Phase 2 | 64 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Aug 9, 2021 | clinicaltrials |
| NCT04986371 | Real-world Study of Niraparib Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer(RENI-1) | unknown | — | 300 | Ling-Ying WuUNKNOWN | 0 | Aug 2, 2021 | clinicaltrials |
| NCT04983550 | Efficacy and Safety of SG001 Combined With PLD in Patients With Platinum-resistant Relapsed EOC | unknown | Phase 2 | 126 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 0 | Jul 30, 2021 | clinicaltrials |
| NCT04974424 | Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV | unknown | — | 20,000 | Huazhong University of Science and TechnologyOTHER | 1 | Jul 23, 2021 | clinicaltrials |
| NCT04973904 | Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer | unknown | Phase 2 | 35 | Peking Union Medical College HospitalOTHER | 1 | Jul 22, 2021 | clinicaltrials |
| NCT04971421 | Liquid Biopsies for Improving the Pre-operative Diagnosis of Ovarian Cancer(OVI-DETECT) | unknown | — | 450 | The Netherlands Cancer InstituteOTHER | 1 | Jul 21, 2021 | clinicaltrials |
| NCT04519593 | ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma | unknown | N/A | 120 | Mother and Child Clinic Saint-PetersburgOTHER | 1 | Jul 14, 2021 | clinicaltrials |
| NCT04961775 | A Prospective Multi-center Study on Using Sonazoid Diagnose Early Stage Endometrial Cancer | unknown | — | 277 | Chinese PLA General HospitalOTHER | 1 | Jul 14, 2021 | clinicaltrials |
| NCT04734665 | Niraparib and Bevacizumab Maintenance Therapy in Platinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP Inhibitor(NIRVANA-R) | unknown | Phase 2 | 44 | Yonsei UniversityOTHER | 1 | Jul 12, 2021 | clinicaltrials |
| NCT04958278 | Pelvic Sentinel Node Detection Using Indocyanine Green Learning Curve(ENDO-GREEN) | unknown | — | 30 | University Hospital, BrestOTHER | 1 | Jul 12, 2021 | clinicaltrials |
| NCT03308604 | AGuIX Gadolinium-based Nanoparticles in Combination With Chemoradiation and Brachytherapy(NANOCOL) | unknown | Phase 1 | 18 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jul 7, 2021 | clinicaltrials |
| NCT03321461 | TMTP1-ICG Mapping in Colposcopy-directed Biopsy | unknown | Phase 1 | 40 | Huazhong University of Science and TechnologyOTHER | 1 | Jun 30, 2021 | clinicaltrials |
| NCT02758652 | Molecular Mechanisms Leading to Chemoresistance in Epithelial Ovarian Cancer(CHEMOVA) | unknown | — | 160 | Tampere University HospitalOTHER | 1 | Jun 22, 2021 | clinicaltrials |
| NCT02785250 | Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer | unknown | Phase 1 / Phase 2 | 85 | ImmunoVaccine Technologies, Inc. (IMV Inc.)INDUSTRY | 2 | Jun 18, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Oct 25, 2021source: clinicaltrials